» Articles » PMID: 38785162

Role of Lactate and Lactate Metabolism in Liver Diseases (Review)

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2024 May 24
PMID 38785162
Authors
Affiliations
Soon will be listed here.
Abstract

Lactate is a byproduct of glycolysis, and before the Warburg effect was revealed (in which glucose can be fermented in the presence of oxygen to produce lactate) it was considered a metabolic waste product. At present, lactate is not only recognized as a metabolic substrate that provides energy, but also as a signaling molecule that regulates cellular functions under pathophysiological conditions. Lactylation, a post‑translational modification, is involved in the development of various diseases, including inflammation and tumors. Liver disease is a major health challenge worldwide. In normal liver, there is a net lactate uptake caused by gluconeogenesis, exhibiting a higher net lactate clearance rate compared with any other organ. Therefore, abnormalities of lactate and lactate metabolism lead to the development of liver disease, and lactate and lactate metabolism‑related genes can be used for predicting the prognosis of liver disease. Targeting lactate production, regulating lactate transport and modulating lactylation may be potential treatment approaches for liver disease. However, currently there is not a systematic review that summarizes the role of lactate and lactate metabolism in liver diseases. In the present review, the role of lactate and lactate metabolism in liver diseases including liver fibrosis, non‑alcoholic fatty liver disease, acute liver failure and hepatocellular carcinoma was summarized with the aim to provide insights for future research.

Citing Articles

Lactate metabolism and lactylation in kidney diseases: insights into mechanisms and therapeutic opportunities.

Cheng Y, Guo L Ren Fail. 2025; 47(1):2469746.

PMID: 40012230 PMC: 11869332. DOI: 10.1080/0886022X.2025.2469746.


Lactate-to-albumin ratio as a potential prognostic predictor in patients with cirrhosis and sepsis: a retrospective cohort study.

Wang J, Chen X, Qin C, Shi R, Huang Y, Gong J BMC Infect Dis. 2025; 25(1):223.

PMID: 39953385 PMC: 11829571. DOI: 10.1186/s12879-025-10601-6.


Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis.

Spampinato M, Giallongo C, Giallongo S, La Spina E, Duminuco A, Longhitano L J Transl Med. 2025; 23(1):69.

PMID: 39810250 PMC: 11734442. DOI: 10.1186/s12967-025-06083-4.


UHT Cow's Milk Supplementation Affects Cell Niches and Functions of the Gut-Brain Axis in BALB/c Mice.

Lemos F, Prins C, Martinez A, Carpi-Santos R, Neumann A, Meireles-da-Costa N Biomedicines. 2024; 12(11).

PMID: 39595015 PMC: 11591918. DOI: 10.3390/biomedicines12112448.


Emerging Role of Extracellular pH in Tumor Microenvironment as a Therapeutic Target for Cancer Immunotherapy.

Rahman M, Yadab M, Ali M Cells. 2024; 13(22).

PMID: 39594672 PMC: 11592846. DOI: 10.3390/cells13221924.


References
1.
Doherty J, Cleveland J . Targeting lactate metabolism for cancer therapeutics. J Clin Invest. 2013; 123(9):3685-92. PMC: 3754272. DOI: 10.1172/JCI69741. View

2.
Pan L, Feng F, Wu J, Fan S, Han J, Wang S . Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells. Pharmacol Res. 2022; 181:106270. DOI: 10.1016/j.phrs.2022.106270. View

3.
Zhao Y, Li W, Li M, Hu Y, Zhang H, Song G . Targeted inhibition of MCT4 disrupts intracellular pH homeostasis and confers self-regulated apoptosis on hepatocellular carcinoma. Exp Cell Res. 2019; 384(1):111591. DOI: 10.1016/j.yexcr.2019.111591. View

4.
Stein M, Lin H, Jeyamohan C, Dvorzhinski D, Gounder M, Bray K . Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies. Prostate. 2010; 70(13):1388-94. PMC: 4142700. DOI: 10.1002/pros.21172. View

5.
Drozdzik M, Szelag-Pieniek S, Grzegolkowska J, Lapczuk-Romanska J, Post M, Domagala P . Monocarboxylate Transporter 1 (MCT1) in Liver Pathology. Int J Mol Sci. 2020; 21(5). PMC: 7084425. DOI: 10.3390/ijms21051606. View